SEC Form 4 · accession 0001209191-15-069827
ARADIGM CORP · ARDM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Juergen Kurt Froehlich
Officer — Chief Medical Officer
Period of report
Sep 1, 2015
Accepted (ET)
Sep 8, 2015 · 7:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013238
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $9.60 | Sep 1, 2015 | J | 37,500 | D | — | Feb 13, 2024 | Common Stock | 37,500 | 0 | D |
| Stock Option (Right to Buy)F2 | $9.60 | Sep 1, 2015 | J | 8,750 | D | — | Feb 13, 2024 | Common Stock | 8,750 | 0 | D |
| Stock Option (Right to Buy)F4,F2,F5 | $9.60 | Sep 1, 2015 | A | 37,499 | A | — | Feb 13, 2024 | Common Stock | 37,499 | 37,499 | D |
| Stock Option (Right to Buy)F2,F5 | $9.60 | Sep 1, 2015 | A | 8,750 | A | — | Feb 13, 2024 | Common Stock | 8,750 | 8,750 | D |
Explanation of responses
- F1Cancellation of Stock Option granted under the now expired Aradigm Corporation 2005 Equity Incentive Plan.
- F2Inapplicable.
- F3Granted under Aradigm Corporation 2015 Equity Incentive Plan.
- F4One share difference in shares granted versus shares cancelled is due to ISO limits and rounding.
- F5Stock option vests 100% upon the satisfaction of certain conditions.